{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:01:07Z","timestamp":1787022067395,"version":"build-2736575974"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T00:00:00Z","timestamp":1594080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["D43TW010313 -01 and D43TW007991),"],"award-info":[{"award-number":["D43TW010313 -01 and D43TW007991),"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0235759","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T13:48:38Z","timestamp":1594129718000},"page":"e0235759","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Proximal renal tubular function in HIV-infected children on tenofovir disoproxil fumarate for treatment of HIV infection at two tertiary hospitals in Harare, Zimbabwe"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2089-182X","authenticated-orcid":true,"given":"Runyararo","family":"Mashingaidze-Mano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutsawashe F.","family":"Bwakura-Dangarembizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles C.","family":"Maponga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene D.","family":"Morse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1572-6790","authenticated-orcid":true,"given":"Tsitsi G.","family":"Monera-Penduka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7327-393X","authenticated-orcid":true,"given":"Takudzwa J.","family":"Mtisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9817-7108","authenticated-orcid":true,"given":"Tinashe","family":"Mudzviti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1615-3856","authenticated-orcid":true,"given":"Hilda A.","family":"Mujuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,7,7]]},"reference":[{"key":"pone.0235759.ref001","unstructured":"Organization WH. Technical update on treatment optimization: use of tenofovir in HIV-infected children and adolescents: a public health perspective. 2012."},{"issue":"10","key":"pone.0235759.ref002","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1097\/QAD.0b013e3280b07b33","article-title":"The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years","volume":"21","author":"MR Nelson","year":"2007","journal-title":"Aids"},{"key":"pone.0235759.ref003","doi-asserted-by":"crossref","DOI":"10.4236\/pp.2014.51015","article-title":"Tenofovir Renal Toxicity: Evaluation of Cohorts and Clinical Studies\u00a1\u00aaPart 2","volume":"5","author":"A Elias","year":"2014","journal-title":"Pharmacology & Pharmacy."},{"key":"pone.0235759.ref004","doi-asserted-by":"crossref","DOI":"10.4236\/pp.2013.49092","article-title":"Tenofovir Renal Toxicity: Evaluation of Cohorts and Clinical Studies\u00a1\u00aaPart One","volume":"4","author":"A Elias","year":"2013","journal-title":"Pharmacology & Pharmacy."},{"key":"pone.0235759.ref005","doi-asserted-by":"crossref","first-page":"562790","DOI":"10.1155\/2011\/562790","article-title":"Nephrotoxicity of HAART.","volume":"2011","author":"R Kalyesubula","year":"2011","journal-title":"AIDS research and treatment"},{"key":"pone.0235759.ref006","doi-asserted-by":"crossref","first-page":"1501785","DOI":"10.1155\/2016\/1501785","article-title":"Urinary Markers of Tubular Injury in HIV-Infected Patients","volume":"2016","author":"T Fiseha","year":"2016","journal-title":"Biochemistry research international"},{"key":"pone.0235759.ref007","unstructured":"Guidelines for Antiretroviral Therapy for the Prevention and Treatment of HIV in Zimbabwe."},{"key":"pone.0235759.ref008","unstructured":"NKF KDOQI GuidelinesAccessed 15 June 2017. Available from: [http:\/\/www2.kidney.org\/professionals\/kdoqi\/guidelines_ckd\/p5_lab_g5.htm]."},{"issue":"1","key":"pone.0235759.ref009","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4103\/1319-2442.106364","article-title":"Prevalence of renal disease in Nigerian children infected with the human immunodeficiency virus and on highly active anti-retroviral therapy","volume":"24","author":"NJ Iduoriyekemwen","year":"2013","journal-title":"Saudi journal of kidney diseases and transplantation: an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia."},{"key":"pone.0235759.ref010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-2431-13-75","article-title":"Renal abnormalities among HIV-infected, antiretroviral naive children, Harare, Zimbabwe: a cross-sectional study","volume":"13","author":"V Dondo","year":"2013","journal-title":"BMC Pediatr"},{"issue":"7","key":"pone.0235759.ref011","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1086\/656361","article-title":"Undiagnosed HIV infection among adolescents seeking primary health care in Zimbabwe.","volume":"51","author":"RA Ferrand","year":"2010","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America."},{"issue":"1","key":"pone.0235759.ref012","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12882-015-0192-4","article-title":"Tenofovir is associated with increased tubular proteinuria and asymptomatic renal tubular dysfunction in Ghana.","volume":"16","author":"DR Chadwick","year":"2015","journal-title":"BMC Nephrology"},{"key":"pone.0235759.ref013","unstructured":"Blossner M, Siyam A, Borghi E, Onyango A, de Onis M, Borghi E, et al. WHO AnthroPlus for Personal Computers Manual: Software for Assessing Growth of the World\u2019s Children and Adolescents."},{"key":"pone.0235759.ref014","unstructured":"WHO. The WHO Child Growth Standards. 2009."},{"key":"pone.0235759.ref015","unstructured":"WHO. Height-for-age (5\u201319 years) [Internet]. WHO. [cited 2017 Jun 12] Available from: http:\/\/wwwwhoint\/growthref\/who2007_height_for_age\/en\/."},{"key":"pone.0235759.ref016","unstructured":"WHO. BMI classification tables for children 5\u201319 years to BMI who\u2014Google Search. Internet[cited 2017 Feb 26] Available from: https:\/\/wwwgooglecom\/search?q=Table++The+International+Classification+of++5-19+yeaarsadolescents++underweight%2C+overweight+and+obesity+according+to+BMI&ie=utf-8&oe=utf-8#safe=active&q=BMI+classification+tables+for+children+5-19+years+++to+BMI+who. 2017."},{"issue":"6","key":"pone.0235759.ref017","first-page":"1153","article-title":"Urinalysis: a comprehensive review","volume":"71","author":"JA Simerville","year":"2005","journal-title":"American family physician"},{"key":"pone.0235759.ref018","first-page":"656","author":"D JT","year":"2012","journal-title":"Handbook of Chronic Kidney Disease Management"},{"key":"pone.0235759.ref019","volume-title":"Serum Inorganic Phosphorus. Clinical Methods: The History, Physical, and Laboratory Examinations","author":"B VK","year":"1990"},{"key":"pone.0235759.ref020","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1093\/clinchem\/35.11.2233","article-title":"An improved pyrogallol red-molybdate method for determining total urinary protein","volume":"35","author":"JL Orsonneau","year":"1989","journal-title":"Clin Chem"},{"key":"pone.0235759.ref021","first-page":"173","article-title":"Measurement of Serum Creatinine\u2013Current Status and Future Goals.","volume":"27","author":"WM Peake *Michael","year":"2006","journal-title":"Clin Biochem Rev"},{"key":"pone.0235759.ref022","doi-asserted-by":"crossref","first-page":"e0133912","DOI":"10.1371\/journal.pone.0133912","article-title":"LC-MS\/MS Method for Serum Creatinine: Comparison with Enzymatic Method and Jaffe Method.","volume":"10","author":"M Ou","year":"2015","journal-title":"PLOS ONE"},{"key":"pone.0235759.ref023","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00467-015-3060-3","article-title":"New standardized cystatin C and creatinine GFR equations in children validated with inulin clearance","volume":"30","author":"UB Berg","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"pone.0235759.ref024","unstructured":"Inker LA WC, Creamer R, Hellinger J, Hotta M, Leppo M, Levey AS, et al. Performance boosted PI+TDF associated with renal function. Conference on Viruses and opportunistic infections:8\u201311 February 2009; Montreal, Canada."},{"key":"pone.0235759.ref025","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.amjmed.2005.02.014","article-title":"Hypophosphatemia: An update on its etiology and treatment","volume":"118","author":"A Gaasbeek","year":"2005","journal-title":"Am J Med"},{"key":"pone.0235759.ref026","unstructured":"DAIDS adverse event clarification memo adult and pediatric adverse events grading the severity\u2014table_for_grading_severity_of_adult_pediatric_adverse_events. 2004Accessed 3 March 2016. Available from: http:\/\/rsc.tech-res.com\/document\/safetyandpharmacovigilance\/table_for_grading_severity_of_adult_pediatric_adverse_events.pdf."},{"key":"pone.0235759.ref027","unstructured":"Grade ES.2004Accessed 23 January 2017. Available from: https:\/\/www.ucdmc.ucdavis.edu\/clinicaltrials\/StudyTools\/Documents\/DAIDS_AE_GradingTable_FinalDec2004.pdf."},{"issue":"6","key":"pone.0235759.ref028","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO).","volume":"67","author":"AS Levey","year":"2005","journal-title":"Kidney International"},{"key":"pone.0235759.ref029","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2165\/00044011-200727080-00006","article-title":"Renal Safety of Tenofovir in HIV-infected Children.","volume":"27","author":"A Vigano","year":"2007","journal-title":"Clin Drug Investig"},{"issue":"8","key":"pone.0235759.ref030","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2165\/00044011-200727080-00006","article-title":"Renal safety of tenofovir in HIV-infected children: a prospective, 96-week longitudinal study.","volume":"27","author":"A Vigano","year":"2007","journal-title":"Clinical drug investigation."},{"issue":"2","key":"pone.0235759.ref031","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/QAD.0b013e328340fdca","article-title":"Prospective study of renal function in HIV-infected pediatric patients receiving tenofovir-containing HAART regimens","volume":"25","author":"P Soler-Palacin","year":"2011","journal-title":"Aids"},{"issue":"6","key":"pone.0235759.ref032","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/QAD.0b013e3283262a64","article-title":"Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir","volume":"23","author":"P Labarga","year":"2009","journal-title":"Aids"},{"key":"pone.0235759.ref033","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1468-1293.2012.01003.x","article-title":"Simultaneous measurement of urinary albumin and total protein may facilitate decision-making in HIV-infected patients with proteinuria.","volume":"13","author":"A Samarawickrama","year":"2012","journal-title":"HIV Med"},{"key":"pone.0235759.ref034","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/prca.201400193","article-title":"Urinary Biomarkers of Kidney Diseases in HIV-infected children","volume":"9","author":"S Perazzo","year":"2015","journal-title":"Proteomics Clin Appl"},{"key":"pone.0235759.ref035","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/COH.0b013e32833f203e","article-title":"Biomarkers of impaired renal function","volume":"5","author":"FA Post","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"pone.0235759.ref036","unstructured":"Fux C, Opravil M, Cavassini M, Calmy A, Flepp M, Gurtner-Delafuente V, et al. Tenofovir and PI Use Are Associated with an Increased Prevalence of Proximal Renal Tubular Dysfunction in the Swiss HIV Cohort Study: boosted PI+TDF associated with renal function. Conference on Viruses and opportunistic infections:8\u201311 February 2009; Montreal, Canada."},{"key":"pone.0235759.ref037","volume-title":"The Washington Manual of Nephrology Subspecialty Consult","author":"S Cheng","year":"2013"},{"key":"pone.0235759.ref038","volume-title":"Diseases of the Kidney and Urinary Tract","author":"R Schrier","year":"2007"},{"key":"pone.0235759.ref039","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2334-12-18","article-title":"Renal function in HIV-infected children and adolescents treated with tenofovir disoproxil fumarate and protease inhibitors.","volume":"12","author":"G Pontrelli","year":"2012","journal-title":"BMC Infect Dis"},{"key":"pone.0235759.ref040","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40261-015-0293-7","article-title":"Long-term Renal Effects of Tenofovir-Disoproxil-Fumarate in Vertically HIV-Infected Children, Adolescents, and Young Adults: A 132-Month Follow-Up Study.","volume":"35","author":"V Giacomet","year":"2015","journal-title":"Clin Drug Investig"},{"key":"pone.0235759.ref041","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.4172\/2155-6113.S4-008","article-title":"Hypophosphatemic Osteomalacia Associated with Tenofovir Use in HIVInfected Patients: A Case Series and Review of the Literature","volume":"01","author":"A Tjen-A-Looi","year":"2012","journal-title":"J AIDS Clin Res"},{"issue":"1","key":"pone.0235759.ref042","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s12879-017-2497-3","article-title":"Clinical and genetic factors associated with kidney tubular dysfunction in a real-life single centre cohort of HIV-positive patients.","volume":"17","author":"SE Salvaggio","year":"2017","journal-title":"BMC infectious diseases."},{"issue":"2","key":"pone.0235759.ref043","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/FPC.0000000000000110","article-title":"A pharmacogenetic candidate gene study of tenofovir-associated Fanconi syndrome","volume":"25","author":"A Dahlin","year":"2015","journal-title":"Pharmacogenetics and genomics"},{"issue":"11","key":"pone.0235759.ref044","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/cid\/cis772","article-title":"Single Nucleotide Polymorphisms in ABCC2 Associate With Tenofovir-Induced Kidney Tubular Dysfunction in Japanese Patients With HIV-1 Infection: A Pharmacogenetic Study","volume":"55","author":"T Nishijima","year":"2012","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"pone.0235759.ref045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.ackd.2009.07.014","article-title":"Screening for chronic kidney disease in HIV-infected patients.","volume":"17","author":"MM Estrella","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"issue":"9","key":"pone.0235759.ref046","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1468-1293.2012.01003.x","article-title":"Simultaneous measurement of urinary albumin and total protein may facilitate decision-making in HIV-infected patients with proteinuria.","volume":"13","author":"A Samarawickrama","year":"2012","journal-title":"HIV Medicine"},{"key":"pone.0235759.ref047","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/ndt\/gfh658","article-title":"Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-na\u00efve HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study.","volume":"20","author":"H Izzedine","year":"2005","journal-title":"Nephrol Dial Transplat"},{"key":"pone.0235759.ref048","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/INF.0b013e31827f4eff","article-title":"Tenofovir Treatment Duration Predicts Proteinuria in a Multi-Ethnic United States Cohort of Children and Adolescents with Perinatal HIV-1 Infection.","volume":"32","author":"M Purswani","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"pone.0235759.ref049","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/nep.12031","article-title":"Prevalence and risk factors for chronic kidney disease among HIV-infected antiretroviral therapy-na\u00efve patients in mainland China: a multicenter cross-sectional study.","volume":"18","author":"Y Cao","year":"2013","journal-title":"Nephrol Carlton Vic"},{"key":"pone.0235759.ref050","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrneph.2009.142","article-title":"The nephrotoxic effects of HAART.","volume":"5","author":"H Izzedine","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"pone.0235759.ref051","first-page":"1","article-title":"Renal dysfunction among anti-retroviral therapy na\u00efve HIV infected patients in Zimbabwe.","volume":"57","author":"GT Fana","year":"2011","journal-title":"Cent Afr J Med"},{"key":"pone.0235759.ref052","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1097\/QAD.0b013e328348a4b1","article-title":"Renal dysfunction among HIV-infected patients starting antiretroviral therapy","volume":"25","author":"L Msango","year":"2011","journal-title":"AIDS"},{"key":"pone.0235759.ref053","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jinf.2013.03.008","article-title":"High prevalence of renal dysfunction and association with risk of death amongst HIV-infected Ghanaians.","volume":"67","author":"FS Sarfo","year":"2013","journal-title":"J Infect"},{"key":"pone.0235759.ref054","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/QAI.0b013e3181dd911e","article-title":"Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir\/lamivudine versus tenofovir\/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study.","volume":"55","author":"FA Post","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pone.0235759.ref055","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/apc.2009.0326","article-title":"Prevalence and factors associated with renal dysfunction among HIV-infected patients","volume":"24","author":"N Crum-Cianflone","year":"2010","journal-title":"AIDS Patient Care STDs"},{"key":"pone.0235759.ref056","unstructured":"Organisation WH. Paediatric ARV drug optimization 3 review [Teleconference\u201412 December 2017,]. 2017 [Summary report]. Available from: https:\/\/www.who.int\/hiv\/pub\/meetingreports\/pado3-review\/en\/index4.html."},{"key":"pone.0235759.ref057","unstructured":"Highleyman L. HIV & AIDS Information: Switching from tenofovi DF to TAF improves bone and kidney safety.Accessed 15 June 2017. Available from: http:\/\/www.aidsmap.com\/Switching-from-tenofovir-DF-to-TAF-improves-bone-and-kidney-safety\/page\/3070140\/."},{"issue":"36","key":"pone.0235759.ref058","doi-asserted-by":"crossref","first-page":"e8046","DOI":"10.1097\/MD.0000000000008046","article-title":"Tenofovir alafenamide nephrotoxicity in an HIV-positive patient: A case report.","volume":"96","author":"TK Novick","year":"2017","journal-title":"Medicine (Baltimore)."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235759","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T09:05:42Z","timestamp":1723194342000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235759"}},"subtitle":[],"editor":[{"given":"Franziska","family":"Theilig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,7,7]]},"references-count":58,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0235759","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.17504\/protocols.io.bfzxjp7n","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,7]]}}}